Yi Xie
State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
ZUP1 promotes DNA repair and immune evasion to drive olaparib resistance in triple-negative breast cancer.
Journal: Journal of advanced research
Published: June 05, 2025
IRF1 transcriptionally activates ALOX15B to enhance ferroptosis sensitivity in triple-negative breast cancer.
Journal: Biochimica et biophysica acta. General subjects
Published: February 10, 2025
Immediate lymphatic reconstruction (ILR) for prevention of secondary lymphedema after breast cancer surgery: a systematic review and meta‑analysis.
Journal: Gland surgery
Published: February 01, 2025
Paracrine Orchestration of Tumor Microenvironment Remodeling Induced by GLO1 Potentiates Lymph Node Metastasis in Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 12, 2025
Response to "A commentary on 'Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery'".
Journal: International journal of surgery (London, England)
Published: October 23, 2024
RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancer.
Journal: Journal of advanced research
Published: December 04, 2023
Identification of lactate-related subgroups and prognostic model in triple-negative breast cancer.
Journal: Journal of cancer research and clinical oncology
Published: June 08, 2023
PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer.
Journal: Cell death discovery
Published: February 28, 2023
Prognosis stratification in breast cancer and characterization of immunosuppressive microenvironment through a pyrimidine metabolism-related signature.
Journal: Frontiers in immunology
Published: September 29, 2022
Last Updated: 09/26/2026